Onco-metabolic surgery: the bridge between curative resection of gastric cancer and the remission of type 2 diabetes mellitus
10.3760/cma.j.cn441530-20231217-00224
- VernacularTitle:肿瘤代谢手术：胃癌根治与2型糖尿病缓解或可兼得
- Author:
Lyujia CHENG
1
;
Zhenpeng WU
;
Yuhan QIAO
;
Yunsong JIANG
;
Lin XIANG
;
Lina WU
;
Bingsheng GUAN
;
Hanlin TANG
;
Shifang HUANG
;
Jingge YANG
Author Information
1. 暨南大学附属第一医院胃肠外科、肥胖与代谢病外科，广州 510630
- Keywords:
Stomach neoplasms;
Type 2 diabetes mellitus;
Onco-metabolic surgery;
Bariatric and metabolic surgery
- From:
Chinese Journal of Gastrointestinal Surgery
2024;27(11):1178-1185
- CountryChina
- Language:Chinese
-
Abstract:
The close relationship between gastric cancer (GC) and type 2 diabetes mellitus (T2DM) has garnered significant attention. On one hand, T2DM may play a role in the development and progression of GC, correlating with poor patient outcomes. On the other hand, after radical surgery for GC, T2DM can be effectively managed, potentially improving tumor prognosis. In recent years, bariatric and metabolic surgery (BMS) has revolutionized T2DM treatment for obese and overweight patients. Comparative analyses reveal similarities between surgical approaches for gastric cancer and BMS, leading to the emergence of the onco-metabolic surgery (OMS) concept, which suggests that radical tumor resection and T2DM remission in GC patients can be potentially achieved through a single procedure. However, there are notable differences between OMS and BMS, including target populations, surgical details, and perioperative management. Therefore, optimizing the application of the OMS concept in GC patients holds significant clinical importance. This article provides a review to facilitate the better implementation of this concept in practice.
